Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Barrett Business Services
BBSI
$761M
| $287K | ﹤0.01% |
+12,948
| New | +$302K |
|
2302
BioLife Solutions
BLFS
$1.7B
| $286K | ﹤0.01% |
+13,173
| New | +$296K |
|
2303
Planet Labs
PL
$8.45B
| $286K | ﹤0.01% |
72,855
+39,292
| +117% | +$176K |
|
2304
WIX.com
WIX
$2.79B
| $285K | ﹤0.01% |
2,853
-400,407
| -99% | -$35.2M |
|
2305
Bally's
BALY
$635M
| $281K | ﹤0.01% |
+14,424
| New | +$283K |
|
2306
NRC Health Common Stock
NRC
$473M
| $281K | ﹤0.01% |
6,473
-24,932
| -79% | -$1.1M |
|
|
ACRE
2307
Ares Commercial Real Estate
ACRE
$262M
| $281K | ﹤0.01% |
+30,965
| New | +$339K |
|
2308
Kanzhun
BZ
$7.49B
| $281K | ﹤0.01% |
14,777
-141
| -0.9% | -$3.08K |
|
|
CFB
2309
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $281K | ﹤0.01% |
+26,873
| New | +$343K |
|
2310
F&G Annuities & Life
FG
$3.51B
| $281K | ﹤0.01% |
+15,490
| New | +$310K |
|
|
EB
2311
DELISTED
Eventbrite
EB
| $279K | ﹤0.01% |
32,527
+19,264
| +145% | +$159K |
|
|
EFC
2312
Ellington Financial
EFC
$1.75B
| $278K | ﹤0.01% |
+22,786
| New | +$294K |
|
|
TRST
2313
Trustco Bank Corp NY
TRST
$953M
| $277K | ﹤0.01% |
+8,691
| New | +$312K |
|
2314
Anavex Life Sciences
AVXL
$325M
| $277K | ﹤0.01% |
32,290
+18,720
| +138% | +$187K |
|
2315
Smith & Wesson
SWBI
$638M
| $277K | ﹤0.01% |
22,482
+11,181
| +99% | +$120K |
|
|
VTLE
2316
DELISTED
Vital Energy
VTLE
| $277K | ﹤0.01% |
+6,079
| New | +$304K |
|
2317
Peoples Bancorp
PEBO
$1.47B
| $276K | ﹤0.01% |
+10,722
| New | +$309K |
|
2318
OrthoPediatrics
KIDS
$633M
| $275K | ﹤0.01% |
+6,223
| New | +$275K |
|
|
CIR
2319
DELISTED
CIRCOR International, Inc
CIR
| $275K | ﹤0.01% |
+8,834
| New | +$241K |
|
2320
Enact Holdings
ACT
$6.75B
| $275K | ﹤0.01% |
+12,014
| New | +$286K |
|
2321
Dorian LPG
LPG
$1.84B
| $273K | ﹤0.01% |
+13,696
| New | +$279K |
|
2322
Argan
AGX
$8.11B
| $273K | ﹤0.01% |
+6,742
| New | +$265K |
|
2323
Leonardo DRS
DRS
$11.9B
| $272K | ﹤0.01% |
+20,922
| New | +$270K |
|
2324
Theravance Biopharma
TBPH
$878M
| $272K | ﹤0.01% |
25,043
+14,055
| +128% | +$149K |
|
2325
GoPro
GPRO
$114M
| $271K | ﹤0.01% |
53,988
+30,247
| +127% | +$163K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.